Amanote Research
Register
Sign In
Cutbacks at England's Cancer Drugs Fund
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2015-016
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
February 10, 2015
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn282 - Cancer Drugs Fund (Cdf) in the United Kingdom: A 2-Year Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn319 - RCT Not Rwe: Two Year Report Card for the Cancer Drugs Fund Reforms
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn239 - Nice and the Cancer Drugs Fund: Appraising Treatments for Rarer Cancers in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn312 - How Has the Relaunched Cancer Drugs Fund Affected Nice’s Approval of Novel Oncology Technologies?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Imperial Cancer Research Fund.
The Lancet
Medicine
UK Newspaper Reporting of the NHS Cancer Drugs Fund, 2010 to 2015: A Retrospective Media Analysis
Journal of the Royal Society of Medicine
Medicine
England's Neglect of Science
Nature
Multidisciplinary